Nystatin; Triamcinolone Acetonide

Drug Usage Statistics, United States, 2006 - 2016

Number of Prescriptions Over Time (2006 - 2016)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2006 463  20
2007 566  103
2008 468  98
2009 423  45
2010 455  32
Year Rank Change
2011 474  19
2012 435  39
2014 370 -
2015 385  15
2016 384  1

Patient Out-Of-Pocket Cost Over Time (2006 - 2016)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2016)
Nystatin 2,464,585
Nystatin; Triamcinolone Acetonide (this drug) 419,823

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Myco-triacet II
  • Mycolog-II
  • Mykacet
  • Mytrex F
  • Nystatin And Triamcinolone Acetonide
  • Nystatin Triamcinolone Acetonide
  • Nystatin-triamcinolone Acetonide
Generic Drug Synonyms and Salts
  • Nystatin; Triamcinolone Acetonide

FDA Approval Information

Established Pharmacologic Class (EPC): Polyene Antifungal
Initial FDA approval date: 5/1/1985
First FDA applicant: Discn
First dosage form: Cream (topical)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2006-2016. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 19.1. Read more about the ClinCalc DrugStats database.


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

©2019 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top